04.03.17
A jury rejected a lawsuit in which a woman claimed that Johnson & Johnson baby powder contributed to her ovarian cancer. The announcement marked a victory for J&J following three similar lawsuits in St. Louis in which juries awarded a total of $197 million to plaintiffs who had made similar claims.
According to the report, the jury voted 11-1 to deny damages to Nora Daniels, the 55 year-old woman from Tennessee, who said she used Johnson & Johnson’s talcum powder from 1978 to 2013, when she was diagnosed with ovarian and uterine cancer. She also sued Imerys Talc. According to Daniel’s lawyer, the jury did not believe the powder caused her specific type of cancer.
Carol Goodrich, global media relations, Johnson & Johnson Consumer, Inc., released the following statement after the verdict:
“We deeply sympathize with the women and families impacted by ovarian cancer. The jury’s decision is consistent with the science, research, clinical evidence and decades of studies by medical experts around the world that continue to support the safety of cosmetic talc,” said Goodrich. “This verdict is in addition to the dismissal of two cases in New Jersey in September 2016 by a state court judge who ruled that plaintiffs’ scientific experts could not adequately support their theories that talcum powder causes ovarian cancer, a decision that highlights the lack of credible scientific evidence behind plaintiffs’ allegations. We are preparing for additional trials this year in St. Louis and other US cities and we will continue to defend the safety of Johnson’s Baby Powder.”
According to the report, the jury voted 11-1 to deny damages to Nora Daniels, the 55 year-old woman from Tennessee, who said she used Johnson & Johnson’s talcum powder from 1978 to 2013, when she was diagnosed with ovarian and uterine cancer. She also sued Imerys Talc. According to Daniel’s lawyer, the jury did not believe the powder caused her specific type of cancer.
Carol Goodrich, global media relations, Johnson & Johnson Consumer, Inc., released the following statement after the verdict:
“We deeply sympathize with the women and families impacted by ovarian cancer. The jury’s decision is consistent with the science, research, clinical evidence and decades of studies by medical experts around the world that continue to support the safety of cosmetic talc,” said Goodrich. “This verdict is in addition to the dismissal of two cases in New Jersey in September 2016 by a state court judge who ruled that plaintiffs’ scientific experts could not adequately support their theories that talcum powder causes ovarian cancer, a decision that highlights the lack of credible scientific evidence behind plaintiffs’ allegations. We are preparing for additional trials this year in St. Louis and other US cities and we will continue to defend the safety of Johnson’s Baby Powder.”
